Iowa Seed Fund II Invests in Coralville-Based VIDA Diagnostics

VIDA Diagnostics, Inc. (“VIDA”), the leader in precision pulmonary informatics, announced the completion of a $5.1 million Series B round of equity financing. Funding was led by Chartline Capital Partners. Rittenhouse Ventures, Next Level Ventures, Rural Vitality Fund II, Iowa Seed Fund II, and Northern California Investment Fund also participated in the round.

The investment will be used to expand Coralville-based VIDA’s commercialization efforts, hire additional talent, and enhance its clinical software and services. VIDA will advance its industry-leading solutions for pulmonary disease management, including lung cancer, COPD, and asthma.

Click here for full release on PRNewswire.

Testimonial

The support and guidance EDC provided Apache gave us a platform to more clearly flush out and define our strategy. We utilize The Recipe as our planning platform. EDC, in no small part, has been part of our growth and success!

Tom Pientok, Apache Inc.

Connect with EDC

  • Stay in touch

    Contact us

    Entrepreneurial Development Center
    230 2nd St. SE, Suite 212
    Cedar Rapids, IA 52401
    Phone: (319) 369-4955
    Fax: (319) 832-1481

    Events

  • Manufacturing a Better Bottom Line
  • Blog Archive

  • Meet Me at the EXPO: Emily Carlson, WRITTEN Apparel
  • 2017 EXPO Exhibitor List Unveiled
  • Meet Us at the EXPO: Tiny But Mighty Popcorn
  • List of 2017 EXPO Presenters Announced
  • Meet Us at the EXPO: Belinda and Rick O’Brien, O’Brien’s Own Granola
  • Meet Me at the EXPO: Tom Lutz, Repour
  • Meet Me at the EXPO: Greg Edwards, WatchPoint Data
  • Top 10 Reasons to Attend EDC’s Annual Meeting April 13th
  • Budgeting for Success
  • International Trade Office Announces FY16 Export Trade Assistance Program
  •